FDA issued a Warning Letter to Inopak Ltd on 2/21/2019 as a result of this inspection.
483 Inopak Jul 2018$119 - Not in Stock
FDA investigators audited the Inopak - Ringwood, NJ, United States facility and issued inspectional observations (via FDA 483) on 20 Jul 2018.
- Category: Human Drugs
- Inspection end: 20 Jul 2018
- Location: Ringwood, United States
- FEI: 1000122232